LEPROSY
(
SEVAMED 2003)
(Diagnosis,
Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis, Vaccines
& Drugs)
January 2003
6102.
Abbot NC, Beck JS, Feval F, Weiss F, Mobayen MH, Ghazi-Saidi K, Dowlati
Y, Velayati AA, Stanford JL.
Immunotherapy with Mycobacterium vaccae and peripheral blood flow in
long-treated leprosy patients, a randomised, placebo-controlled trial. Eur J
Vasc Endovasc Surg. 2002 Sep;24(3):202-8.
6103.
Bakker MI, Hatta M, Kwenang A, Klatser PR, Oskam L. Epidemiology of
leprosy on five isolated islands in the Flores Sea, Indonesia. Trop Med Int
Health. 2002 Sep;7(9):780-7.
6104.
Dhar S; Dhar S Department of Dermatopathology Clinic AMRI- Apollo
Hospital, Kolkatta. Histopathological features of granulomatous skin diseases :
an analysis of 22 skin biopsies Indian Journal of Dermatology . 2002; 47(2):
88-90
6105.
Halder Biswas A, Mundle M, Bhadra U K, Mishra R, Mahapatra B S. Study of
leprosy cases among contacts in West Bengal. Indian J Commun Med 2001; 26(2),
76-9.
6106.
Nanavaty M A, Nanavaty A J, Lakhani J D, Lakhani S J, Vasavada A R.
Subconjunctival adult bancroftian filaria worm. Indian J Opthal 2001; 49(3),
985-6.
6107.
Ottenhoff TH. Mycobacterium leprae and demyelination. Science. 2002 Aug
30;297(5586):1475-6; discussion 1475-6.
6108.
Siddiqui MR, Moreira AL, Negesse Y, Taye GA, Hanekom WA, Haslett PA,
Britton S, Kaplan G. Local nerve damage in leprosy does not lead to an impaired
cellular immune response or decreased wound healing in the skin. J Infect Dis.
2002 Jul 15;186(2):260-5.
6109.
Singh N, Arora VK, Jain A, Bhattacharya SN, Bhatia A. Cytology of
testicular changes in leprosy. Acta Cytol. 2002 Jul-Aug;46(4):659-63.
Pathogenesis:
6110.
Maeda Y, Makino M, Crick DC, Mahapatra S, Srisungnam S, Takii T,
Kashiwabara Y, Brennan PJ. Novel 33-kilodalton lipoprotein from Mycobacterium
leprae. Infect Immun. 2002 Aug;70(8):4106-11.
6111. Wibawa T, Soebono H, Matsuo M. Association of a missense mutation of the laminin alpha2 gene with tuberculoid type of leprosy in Indonesian patients. Trop Med Int Health. 2002 Jul;7(7):631-6.
Therapy:
6112.
Baughman RP, Judson MA, Teirstein AS, Moller DR, Lower EE. Thalidomide
for chronic sarcoidosis. Chest
2002 Jul;122(1):227-32
6113.
Silverman WA. The schizophrenic career of a "monster drug".
Pediatrics 2002
Aug;110(2 Pt 1):404-6
6114. Tomimori-Yamashita J, Maeda SM, Sunderkotter C, Kaminsky SK, Michalany NS, Rotta O, Castro RM. Leukomelanodermic leprosy. Int J Dermatol 2002 Aug;41(8):513-5
April 2003
6772.
Belliappa AD, Bhat RM, Martis J. Leprosy in type I reaction and diabetes
mellitus in a patient with HIV infection. Int J Dermatol
2002 Oct;41(10):694-5.
6773.
Dhar S; Dhar S. Histopathological features of granulomatous skin diseases
: an analysis of 22 skin biopsies
Indian Journal of Dermatology . 2002; 47(2): 88-90.
6774.
Ghosh A K ,Ghosal A M ,Gangopadhyay D N,Bhattacharjee K,Roy M Dutta R N
.Status of leprosy patients
after W.H.O. MDT- a Surviellance Study .Indian J Derm 2001, 46(1),30-2.
Pathogenesis:
6775. Santos AR, Suffys PN, Vanderborght PR, Moraes MO, Vieira LM, Cabello PH, Bakker AM, Matos HJ, Huizinga TW, Ottenhoff TH, Sampaio EP, Sarno EN. Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosy. J Infect Dis 2002 Dec 1;186(11):1687-91.
July 2003
7294.
De Carsalade GY, Achirafi A, Flageul B.
Pentoxifylline in the treatment of erythema nodosum leprosum. J Dermatol.
2003 Jan;30(1):64-8.
7295.
Franco-Paredes C, Guarner J, Mehrabi D, McCall C, del Rio C. Clinical and
pathological recognition of leprosy. Am J Med. 2003 Feb 15;114(3):246-7.
7296.
Ishii N. Recent
advances in the treatment of leprosy. Dermatol Online J. 2003 Mar;9(2):5.
7297.
Lawn SD, Wood C, Lockwood DN.
Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a
human immunodeficiency virus-infected person. Clin Infect Dis. 2003 Jan
1;36(1):e5-6.
7298.
Murray CK, Joyce MP, Longfield RN.
Short report: Treatment failure in Hansen's disease. Am J Trop Med Hyg.
2003 Feb;68(2):233-4.
7299.
Rajesh M, Sulochana KN, Sundaram AL, Krishnakumar S, Biswas J,
Ramakrishnan S. Presence
of a 88 kDa Eales protein in uveitis, tuberculosis, leprosy and rheumatoid
arthritis. Med Sci Monit. 2003 Feb;9(2):CR95-9.
7300.
Thomas R, Thomas S, Muliyil J. Prevalence of glaucoma in treated
multibacillary Hansen disease. J Glaucoma. 2003 Feb;12(1):16-22.
7301. Turkof E, Richard B, Assadian O, Khatri B, Knolle E, Lucas S. Leprosy affects facial nerves in a scattered distribution from the main trunk to all peripheral branches and neurolysis improves muscle function of the face. Am J Trop Med Hyg. 2003 Jan;68(1):81-8.
7302. Ulvi H, Yoldas T, Yigiter R, Mungen B. R-R interval variation and the sympathetic skin response in the assessment of the autonomic nervous system in leprosy patients. Acta Neurol Scand. 2003 Jan;107(1):42-9.
Pathogenesis
7303.
Kiszewski CA, Becerril E, Baquera J, Aguilar LD, Hernandez-Pando R.
Expression of transforming growth factor-beta isoforms and their receptors in
lepromatous and tuberculoid leprosy. Scand J Immunol
2003 Mar;57(3):279-85
7304.
Mira MT, Alcais A, Van Thuc N, Thai VH, Huong NT, Ba NN, Verner A, Hudson
TJ, Abel L, Schurr E. Chromosome 6q25 is linked to susceptibility to leprosy in
a Vietnamese population. Nat Genet
2003 Mar;33(3):412-5
7305.
Oliveira RB, Ochoa MT, Sieling PA, Rea TH, Rambukkana A, Sarno EN, Modlin
RL. Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of
nerve damage in leprosy. Infect Immun
2003 Mar;71(3):1427-33
Therapy:
7306.
Cheadle EJ, Selby PJ, Jackson AM.Mycobacterium bovis bacillus
Calmette-Guerin-infected dendritic cells potently activate autologous T cells
via a B7 and interleukin-12-dependent mechanism. Immunology
2003 Jan;108(1):79-88
October 2003
8032.
Ang P, Tay YK, Ng SK, Seow CS. Fatal Lucio's phenomenon in 2 patients
with previously undiagnosed leprosy. J Am Acad Dermatol. 2003 Jun;48(6):958-61.
8033. Hernandez MO, Neves I, Sales JS, Carvalho DS, Sarno EN, Sampaio EP. Induction of apoptosis in monocytes by Mycobacterium leprae in vitro: a possible role for tumour necrosis factor-alpha. Immunology. 2003 May;109(1):156-64.
8034.
Mehdi G, Maheshwari V, Gaur S, Sharma R. Histoid leprosy: diagnosis by
fine needle aspiration cytology. Acta Cytol. 2003 May-Jun;47(3):529-31.
8035.
Singh N, Malik A, Arora VK, Bhatia A. Fine needle aspiration cytology of
leprous neuritis. Acta Cytol. 2003 May-Jun;47(3):368-72.
Pathogenesis:
8036. Bochud PY, Hawn TR, Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol. 2003 Apr 1;170(7):3451-4.
Therapy:
8037.
Durrheim DN, Speare R. Global leprosy elimination: time to change more
than the elimination target date. J Epidemiol Community Health. 2003
May;57(5):316-7.